article thumbnail

Ortho-Phthalates Retain FDA Approval for Food Packaging Despite Petitions

XTalks

Last week, the US Food and Drug Administration (FDA) stood by its decision, denying a petition asking it to reevaluate the use of eight ortho-phthalates in food-contacting packaging materials. Related: Is Fiber Based Packaging the Next Trend in Sustainable Food Packaging?

article thumbnail

Celltrion’s Yuflyma receives US FDA approval for multiple conditions

Pharmaceutical Technology

Yuflyma represents the company’s fifth biosimilar and second anti-TNF biosimilar to receive US FDA approval. The regulatory approval was based on a comprehensive data package of preclinical, analytical and clinical trials. It will be offered to patients in prefilled syringe and autoinjector administration options.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Merck’s Chronic Cough Drug Fails to Secure FDA Approval for Second Time

BioSpace

The regulator’s Complete Response Letter on Wednesday said Merck’s data package for gefapixant “did not meet substantial evidence of effectiveness.” The FDA also rejected the drug in 2022 due to a lack of efficacy evidence.

article thumbnail

Ortho-Phthalates in Food Packaging + McDonald’s New Restaurant Idea – Xtalks Food Podcast Ep. 121

XTalks

Last month, the US Food and Drug Administration (FDA) stood by its decision, denying a petition asking it to reevaluate the use of eight ortho-phthalates in food-contacting packaging materials.

article thumbnail

GE Healthcare’s Clariscan™ (gadoterate meglumine) Becomes Only FDA-Approved MRI Contrast Agent Available in Polymer Bottle

BioTech 365

US FDA approves +PLUSPAK™ (polymer bottle) Pharmacy Bulk Package for the gadolinium-based contrast agent, Clariscan™ (gadoterate meglumine) As the only polymer bottle for an MRI contrast agent, Clariscan in +PLUSPAK offers the potential for increased workplace safety, efficiency, convenience and … Continue reading →

article thumbnail

What is the Difference Between Biologics and Biosimilars?

Pharma Packaging Solutions

A biosimilar is a biologic that is similar enough to an existing FDA-approved product that it performs in exactly the same way, but different enough to avoid legal battles with the producers of the original product. At Tjoapack, we provide a range of top of the line biopharma packaging solutions. What are Biosimilars?

article thumbnail

Impulse Dynamics Announces FDA Approval for Magnetic Resonance Imaging

The Pharma Data

Further, combined with the early successes in improving cardiac performance, now when combined with MRI compatibility, CCM adds to the armamentarium of the cardiologist and electrophysiologist in further optimizing FDA-approved medical therapies in 2021.”